Please select a valid location from the dropdown
Clear All
Advanced search
Advanced Filters

Found 6 Lung trials

Below is a list of actively recruiting clinical trials based on your search for "Lung"

Program with 2 clinical trials

Chronic Obstructive Pulmonary Disease (COPD)

These clinical studies are investigating the safety and efficacy of an investigational medication for patients with moderate to severe COPD and who are either current smokers or have a history of smoking.
Check Eligibility
Featured study

Investigating Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) with Investigational Medication

40 years - 85 years
All genders
Phase 4
Interventional
This study investigates chronic obstructive pulmonary disease (COPD).The study evaluates how the investigational medication affects airway inflammation and its relationship to lung function and quality of life.Who can participate: Participants aged 40 to 85 years with COPD may join. Key factors include being a current or former smoker with a …
About the study

Investigational Medication for Chronic Lung Allograft Dysfunction Post-Lung Transplant

18 years or above
All genders
Phase 3
Interventional
This study investigates chronic lung allograft dysfunction. The purpose of this study is to understand more about this condition in adults who have had a lung transplant.The study evaluates how effective and safe the investigational medication is when compared to a placebo. It focuses on understanding its effects when added …
About the study

Study of Investigational Medication in Adults with Advanced Solid Tumors

18 years or above
All genders
Phase 1
Interventional
This study investigates advanced solid tumors. Participants must have cancer that has come back or did not improve with treatment. The purpose of this study is to evaluate the safety of an investigational medication in participants with solid tumors that are hard to treat or have spread throughout the body.The …
About the study

Study on Treatments for Lung Disease in Systemic Sclerosis

18 years or above
All genders
Phase 2
Interventional
This study investigates the effectiveness of different investigational medications compared to a placebo in improving lung capacity in participants with Interstitial Lung Disease (ILD) secondary to Systemic Sclerosis (SSc). The purpose is to observe changes from the start to the end of the treatment period at Week 52.Participants in the …
About the study

Investigating the Impact of AI Tools on COPD Follow-Up

40 years or above
All genders
Observational
This study investigates COPD exacerbation. It looks into how an AI-enabled clinical workflow tool might affect follow-up care by respiratory specialists.The study focuses on evaluating the impact of this tool on clinical outcomes. It examines how the tool might help in managing care after an acute exacerbation.Who can participate: Participants …
About the study